HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Volker Breu Selected Research

Infarction (Infarctions)

7/2005Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Volker Breu Research Topics

Disease

1Aneurysm (Aneurysms)
07/2005
1Infarction (Infarctions)
07/2005
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
07/2005
1Intracranial Vasospasm
07/2005

Drug/Important Bio-Agent (IBA)

1clazosentanIBA
07/2005
1Endothelins (Endothelin)IBA
07/2005
1Endothelin A ReceptorIBA
07/2005